Gene · 11277
Papers2,317
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,317
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Expanding the spectrum of genetic causes of DNA-specific exonuclease TREX1 variants in thrombotic microangiopathy. | Kidney Int | 2025 | 40383229 | PubTator, text mining | PubMed |
| Prevalence and Characteristics of Pathogenic Variants in Taiwanese Patients With Cerebral Small Vessel Disease. | Neurol Genet | 2025 | 40343074 | PubTator, text mining | PubMed |
| Deep mutational scanning and CRISPR-engineered viruses: tools for evolutionary and functional genomics studies. | mSphere | 2025 | 40272173 | PubTator, text mining | PubMed |
| High Tumor Mutation Burden (TMB) and a Novel Somatic Mutation in the TREX1 Gene in a Patient with Aggressive and Refractory High-Grade B-Cell Lymphoma: A Case Report. | Int J Mol Sci | 2025 | 40243506 | PubTator, text mining | PubMed |
| A Metformin-Based Multifunctional Nanoplatform as a DNA Damage Amplifier for Maximized Radio-Immunotherapy to Overcome Radiotherapy Resistance. | ACS Nano | 2025 | 40207668 | PubTator, text mining | PubMed |
| Exome sequencing of a Portuguese cohort of early-onset Alzheimer's disease implicates the X-linked lysosomal gene GLA. | Sci Rep | 2025 | 40185916 | PubTator, text mining | PubMed |
| Delayed Diagnosis of Aicardi-Goutières Syndrome in a 10-Year-Old Female Child With TREX1 Mutation: A Case Report. | Cureus | 2025 | 40161088 | PubTator, text mining | PubMed |
| The DNase TREX1 is a substrate of the intramembrane protease SPP with implications for disease pathogenesis. | Cell Mol Life Sci | 2025 | 40072623 | PubTator, text mining | PubMed |
| Two rare mutations in homozygosity synergize to silence TREX1 in Aicardi-Goutières syndrome. | Front Immunol | 2025 | 40061936 | PubTator, text mining | PubMed |
| Effect of methyl DNA adducts on 3'-5' exonuclease activity of human TREX1. | Biochem J | 2025 | 39998308 | PubTator, text mining | PubMed |
| Correction: Three prime repair exonuclease 1 preferentially degrades the integration-incompetent HIV-1 DNA through favorable kinetics, thermodynamic, structural, and conformational properties. | J Biol Chem | 2025 | 39952080 | PubTator, text mining | PubMed |
| Correction to: Anifrolumab in Monogenic Lupus caused by TREX1 Mutation. | J Clin Immunol | 2025 | 39899156 | PubTator, text mining | PubMed |
| TREX1-Associated Familial Chilblain Lupus With Cerebral Aneurysms Treated With Janus Kinase Inhibition. | J Rheumatol | 2025 | 39892888 | PubTator, text mining | PubMed |
| The c.529G>A (p.Ala177Thr) RNASEH2B Gene Pathogenic Variant as a First-Line Genetic Test for Aicardi-Goutières Syndrome: A Case Series of Four Moroccan Families. | Am J Med Genet A | 2025 | 39890436 | PubTator, text mining | PubMed |
| Whole genome sequencing of 10 families with optic disc drusen. | Ophthalmic Genet | 2025 | 39865650 | PubTator, text mining | PubMed |
| A central role of stimulator of interferon genes' adaptor protein in defensive immune response. | Immunol Res | 2025 | 39836303 | PubTator, text mining | PubMed |
| Cobalt Chloride-Mimicked Hepatocyte Cell Hypoxia Induces TREX1, Leading to Hepatitis B Virus Restriction. | J Infect Dis | 2025 | 39761821 | PubTator, text mining | PubMed |
| Tissue factor promotes TREX1 protein stability to evade cGAS-STING innate immune response in pancreatic ductal adenocarcinoma. | Oncogene | 2025 | 39658648 | PubTator, text mining | PubMed |
| Reverse transcriptase inhibitors in Aicardi-Goutières syndrome: A crossover clinical trial. | Dev Med Child Neurol | 2025 | 39630935 | PubTator, text mining | PubMed |
| Prime editing: therapeutic advances and mechanistic insights. | Gene Ther | 2025 | 39609594 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11277/papers?page=6